De Novo Design of Proteins - Peptide and Protein Design for Biopharmaceutical Applications - page 245

[150] C. M. Goodman, S. Choi, S. Shandler and W. F. DeGrado, Foldamers as versatile
frameworks for the design and evolution of function, Nature Chem. Biol ., 3,
252-262 (2007).
[151] R. Cheng, S. Gellman and W. F. DeGrado, b-peptides: From structure to function,
Chem. Rev ., 101, 3219-3232 (2001).
[152] H. S. Lee, F. A. Syud, X. Wang and S. H. Gellman, Diversity in short b-peptide 12-
helices: High-resolution structural analysis in aqueous solution of a hexamer con-
taining sulfonylated pyrrolidine residues, J. Am. Chem. Soc ., 123, 7721-7722
(2001).
[153] S. A. W. Gruner, V. Truffault, G. Voll, E. Locardi, M. St¨ ckle and H. Kessler,
Design, synthesis, and NMR structure of linear and cyclic oligomers containing
novel furanoid sugar amino acids, Chem. Eur. J ., 8, 4366-4376 (2002).
[154] M. Rueping, J. V. Schreiber, G. Lelais, B. Jaun and D. Seebach, Mixed b 2 /b 3 -
hexapeptides and b 2 /b 3 -nonapeptides folding to ( P )-helices with alternating twelve-
and ten-membered hydrogen-bonded rings, Helv. Chim. Acta , 85, 2577-2593
(2002).
[155] W. C. Pomerantz, N. L. Abbott and S. H. Gellman, Lyotropic liquid crystals from
designed helical b-peptides, J. Am. Chem. Soc ., 128, 8730-8731 (2006).
[156] J. K. Murray and S. H. Gellman, Application of microwave irradiation to the
syntehsis of 14-helical b-peptides, Org. Lett ., 7, 1517-1520 (2005).
[157] J. X. Qiu, E. J. Petersson, E. E. Matthews and A. Schepartz, Toward b-amino acid
proteins: A cooperatively folded b-peptide quaternary structure, J. Am. Chem. Soc .,
128, 11338-11339 (2006).
[158] D. S. Daniels, E. J. Petersson, J. X. Qiu and A. Schepartz, High-resolution structure
of a b-peptide bundle, J. Am. Chem. Soc ., 129, 1532-1533 (2007).
[159] E. J. Petersson, C. J. Craig, D. S. Daniels, J. X. Qiu and A. Schepartz, Biophysical
characterization of b-peptide bundle, comparison to natural proteins, J. Am. Chem.
Soc ., 129, 5344-5345 (2007).
[160] J. L. Goodman, E. J. Petersson, D. S. Daniels, J. X. Qiu and A. Schepartz,
Biophysical and structural characterization of a robust octameric b-peptide bundle,
J. Am. Chem. Soc ., 129, 14746-14751 (2007).
[161] E. J. Petersson and A. Schepartz, Toward b-amino acid proteins: design, synthesis,
and characterization of a fifteen kilodalton b-peptide tetramer, J. Am. Chem. Soc .,
130, 821-823 (2008).
[162] S. L. LaPorte, C. M. Forsyth, B. C. Cunningham, L. J. Mierke, D. Akhavan and R.
M. Stroud, De novo design of an IL-4 antagonist and its structure at 1.9 ˚ , PNAS ,
102, 1889-1894 (2005).
[163] C. Chothia, M. Levitt and D. Richardson, Helix to helix packing in proteins, J. Mol.
Biol ., 145, 215-250 (1981).
[164] T. Matthews, M. Salgo, M. Greenberg, J. Chung, R. DeMasi and D. Bolognesi,
Enfuvirtide: The first therapy to inhibit the entry of HIV-1 into host CD4 lympho-
cytes, Nature Rev. Drug Discovery , 3, 215-225 (2004).
[165] C. Wild, T. Oas, C. McDanal, D. Bolognesi and T. Matthews, A synthetic peptide
inhibitor of human immunodeficiency virus replication: Correlation between solu-
tion structure and viral inhibition, PNAS , 89, 10537-10541 (1992).
[166] C. Wild, J. W. Dubay, T. Greenwell, T. Baird, T. G. Oas, C. McDanal, E. Hunter
and T. Matthews, Propensity for a leucine zipper-like domain of human immuno-
deficiency virus type 1 gp41 to form oligomers correlates with a role in virus-